Overview

Effects of ONO-2506PO in Patients With Alzheimer's Disease

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.
Phase:
Phase 2
Details
Lead Sponsor:
Ono Pharma USA Inc